Allison Luo
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)The University of Texas Health Science Center at San Antonio(US)Prometheus Biosciences (United States)(US)The University of Texas Health Science Center at Houston(US)
Publications by Year
Research Areas
Inflammatory Bowel Disease, Microscopic Colitis, Immunodeficiency and Autoimmune Disorders, Chronic Lymphocytic Leukemia Research, Helicobacter pylori-related gastroenterology studies
Most-Cited Works
- Immune responses following administration of influenza and pneumococcal vaccines to patients with rheumatoid arthritis receiving adalimumab.(2007)
- → A phase II, randomized, double‐blind, placebo‐controlled study evaluating the efficacy and safety of MDX‐1100, a fully human anti‐CXCL10 monoclonal antibody, in combination with methotrexate in patients with rheumatoid arthritis(2011)195 cited
- → Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study(2013)189 cited
- → Abatacept for Crohn's Disease and Ulcerative Colitis(2012)137 cited
- → Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program(2013)135 cited
- → Reliability among central readers in the evaluation of endoscopic findings from patients with Crohn's disease(2015)110 cited